Cargando…
Leukotoxicity after moderately Hypofractionated radiotherapy versus conventionally fractionated dose escalated radiotherapy for localized prostate Cancer: a secondary analysis from a randomized study
BACKGROUND: To compare WBC counts during treatment of localized prostate cancer with either conventionally fractionated (CF) or moderately hypofractionated (HYPO) radiotherapy. METHODS: Weekly blood test results were extracted from the charts of patients treated within a phase III study comparing HY...
Autores principales: | Sanguineti, Giuseppe, Giannarelli, Diana, Petrongari, Maria Grazia, Arcangeli, Stefano, Sangiovanni, Angelo, Saracino, Biancamaria, Farneti, Alessia, Faiella, Adriana, Conte, Mario, Arcangeli, Giorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352380/ https://www.ncbi.nlm.nih.gov/pubmed/30700317 http://dx.doi.org/10.1186/s13014-019-1223-2 |
Ejemplares similares
-
Modeling of α/β for late rectal toxicity from a randomized phase II study: conventional versus hypofractionated scheme for localized prostate cancer
por: Marzi, Simona, et al.
Publicado: (2009) -
Dose escalation using ultra-high dose IMRT in intermediate risk prostate cancer without androgen deprivation therapy: preliminary results of toxicity and biochemical control
por: Petrongari, Maria Grazia, et al.
Publicado: (2013) -
Refinement & validation of rectal wall dose volume objectives for prostate hypofractionation in 20 fractions
por: Sanguineti, Giuseppe, et al.
Publicado: (2020) -
Moderately Escalated Hypofractionated (Chemo) Radiotherapy Delivered with Helical Intensity-Modulated Technique in Stage III Unresectable Non-Small Cell Lung Cancer
por: Donato, Vittorio, et al.
Publicado: (2013) -
Moderate hypofractionation for prostate cancer
por: Arcangeli, Stefano, et al.
Publicado: (2017)